The Diabetes Control and Complications Trial showed a trend toward a 41% risk reduction of cardiovascular events in type 1 diabetic patients ( 48 ).
← all excerpts
The Burden of Cardiovascular Disease Attributable to Modifiable Risk Factors and Cost-effectiveness Analysis of IraPEN Program in the General Population of Iran.
1
—
—